EGLN3 and neoplasm: Comparison between patients in the PHD3(+)/FIH(+) group and PHD3(–)/FIH(–) group was performed by χ2 test with the Bonferroni correction, as seen in Supplementary Table 3, indicating that PHD3(–)/FIH(–) patients had an obviously lower chance of forming tumor encapsulation but higher chance of TNM stage than PHD3(+)/FIH(+) patients (p < 0.0083).